Get the Stockscreener App
14.21
0.92%
0.13
Inmode Ltd stock is traded at $14.21, with a volume of 289.23K.
It is up +0.92% in the last 24 hours and down -3.92% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
See More
Previous Close:
$14.08
Open:
$14.05
24h Volume:
289.23K
Relative Volume:
0.67
Market Cap:
$817.70M
Revenue:
$374.64M
Net Income/Loss:
$87.19M
P/E Ratio:
10.41
EPS:
1.365
Net Cash Flow:
$90.65M
1W Performance:
+0.85%
1M Performance:
-3.92%
6M Performance:
+3.80%
1Y Performance:
-10.57%
1-Day Range:
$14.05
$14.22
1-Week Range:
$13.86
$14.22
52-Week Range:
$12.72
$16.74
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.21 | 817.70M | 374.64M | 87.19M | 90.65M | 1.365 |
ABT
Abbott Laboratories
|
99.60 | 172.35B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.48 | 113.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
277.33 | 106.38B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.73 | 61.93B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.21 | 49.12B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
Body Contouring Devices Market Expands as Non-Invasive Technology Reaches Untapped Male Demographic - GlobeNewswire Inc.
InMode (INMD) Stock Today: Unchanged at $14.62, Key Levels 2026-09-17Seasonality Effect - siam.in
InMode slips as unsolicited takeover bid expires (INMD:NASDAQ) - Seeking Alpha
Wellington Management Group LLP Invests $1.25 Million in InMode Ltd. $INMD - MarketBeat
Behavioral Patterns of INMD and Institutional Flows - Stock Traders Daily
InMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from Brokerages - MarketBeat
InMode Ltd. Announces Launch Of Morpheus8 Cool On Morpheus8MAX Platform - marketscreener.com
InMode launches Morpheus8 Cool, enhancing RF mi... - Pluang
A new cooling tip brings more comfort to microneedling - Stock Titan
Bank of America Corp DE Sells 236,577 Shares of InMode Ltd. $INMD - MarketBeat
InMode Ltd. (INMD) Key Financial Ratios – Valuation, Profitability & More - Value Research
InMode stock holds steady as investors eye latest growth figures - ad-hoc-news.de
InMode Ltd. (INMD) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
InMode (NASDAQ:INMD) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
(INMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
InMode (NASDAQ:INMD): Is A New Trading Phase Emerging? - Kalkine Media
InMode (INMD) Results Breakdown: The Available Earnings Metric Delivers a Beat in Latest Trading; Investor Response: Shares Close 0.80% Lower on the DayTax Rate Impact - vinanet.vn
InMode (INMD) Results Breakdown: The Available Earnings Metric Delivers a Beat in Latest Trading; Investor Response: Shares Close 0.80% Lower on the DayEarnings Yield Spread - careplusvn.com
InMode (INMD) Results Breakdown: The Available Earnings Metric Delivers a Beat in Latest Trading; Investor Response: Shares Close 0.80% Lower on the DayConsensus Miss Rate - dars.gov.et
InMode (INMD) Holds Steady at $15.15 as Stock Consolidates Between Key Support and ResistanceMomentum Trade - vinanet.vn
InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
154: Static price chart | InMode Ltd. | IL0011595993 - marketscreener.com
North Growth Management Ltd.'s InMode Ltd(INMD) Holding History - GuruFocus
InMode (INMD) wins denial of urgent injunction request in Israeli court - Stock Titan
(INMD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Cash flow from financing activities of InMode Ltd. – HAM:154 - TradingView
Revenue per share of InMode Ltd. – HAM:154 - TradingView
Long term debt to total equity ratio of InMode Ltd. – HAM:154 - TradingView
Steadtrust LLC Boosts Position in InMode Ltd. $INMD - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK) - The Globe and Mail
Inmode Ltd (INMD) Stock News Today - TradingKey
InMode Ltd. (INMD) Stock Analysis: Evaluating Growth Potential in the Medical Device Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages InMode Ltd. (INMD) Investors to Inquire about Securities Investigation - The National Law Review
InMode (INMD) Stock Margin Compression Deepens As Profitability Fades - simplywall.st
InMode reports stable Q2 2026 revenue at $95.6M, with a 13% rise in consumables sales and $501M cash reserves. - Pluang
Needham Maintains InMode(INMD.US) With Hold Rating - moomoo.com
InMode Ltd. (NASDAQ: INMD) CFO awarded 14,000 RSUs and reports holdings - Stock Titan
InMode (NASDAQ:INMD) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 - Morningstar
InMode Ltd. reports results for the quarter ended June 30Earnings Summary - TradingView
INMODE OUTLOOK FY ADJUSTED EPS USD 1.29-1.34 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Earnings Flash (INMD) InMode Ltd. Posts Q2 Adjusted EPS $0.35 per Share, vs. FactSet Est of $0.33 - marketscreener.com
Earnings Flash (INMD) InMode Ltd. Reports Q2 Revenue $95.6M, vs. FactSet Est of $93.1M - marketscreener.com
InMode: Q2 Earnings Snapshot - marketscreener.com
InMode: Q2 Earnings Snapshot - Barchart.com
InMode Q2 2026 Earnings: Flat Revenue and Lower Margins - tradingkey.com
Earnings Flash (INMD) InMode Ltd. Reports Q2 Revenue $95.6M, Vs. FactSet Est of $93.1M - Moomoo
Tranche Update on InMode Ltd.'s Equity Buyback Plan announced on March 13, 2026. - marketscreener.com
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 - finance.yahoo.com
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
2.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):